3Wahlgren N,Ahmed N,Ddvalos A,et al. Tbrombolysis with al- teplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study(SITS-MOST).. an observational study[J]. Lancet,2007,369(9558) :275-282.
3Zaharehuk G, E1 Mogy I S, Fischbein N J, et al. Comparison of arterial spin labeling and bolus perfusion weighted imaging for deteeting mismateh in aeute stroke[J]. Stroke. 2012,43(7) 1843-1848.
4Wahlgren N,Ahmed N,Gavalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementa- tion of Thrombolysis in Stroke-Monitoring Study (SITS- MOST) ,an observational study[J]. Lancet,2007,369(9558) : 275-282.
5Zangerle A, Kiecbl S, Spiegel M, et al. Recanalization after thrombolysis in stroke patienst: predictors and prognostic im- plications[J]. Neurology, 2007,68 (I) 39- 44.
6Ribo M, Alvarez-Sabin J, Montaner J, et al. Temporal profile o{ recanalization after intravenous tissue plagminogen activa- tor:selecting patient for recue reperfusion technlque[J]. Stroke, 2006,37(4) 1000-1004.
7Serna-Candel C, Lopez-Ibor L, Matias-Guiu J. Endovascular treatment for acute stroke:an open field to begin[J]. Neuto- logia,2010.25(5) :273 278.
8Buoderick J P,Palesch Y Y,Demchuk A M,et al. Endovascu lar therapy after intravenous t-PA versus t-PA alone for stroke[J]. N Engl J Med,2013,368(13) :1265-1270.
9Connors J J. Pharmacologie Agents in Stroke Prevention, A- cute Stroke Therapy and Interventional Procedures[J]. J Vasc lnterv Rsdiol,2004,15(1) :87-101.
